Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2023 Feb 14;70:104549. doi: 10.1016/j.msard.2023.104549

Corrigendum to ’To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection’[Multiple sclerosis and related disorders vol. 65 (2022) 104014]

Dominika Stastna a, Ingrid Menkyova a,b, Jiri Drahota a,c, Tereza Hrnciarova a, Eva Kubala Havrdova a, Marta Vachova a,d, Michaela Andelova a, Pavlina Kleinova a, Ivana Kovarova a, Eva Krasulova a, Jana Lizrova Preiningerova a, Iveta Novakova a, Klara Novotna a, Martina Novotna a, Petra Nytrova a, Jana Pavlickova a, Barbora Srpova a, Katerina Storey a, Veronika Ticha a, Michaela Tyblova a, Tomas Uher a, Karolina Vodehnalova a, Dana Horakova a,⁎
PMCID: PMC9926161  PMID: 36796224

The authors regret that there in an error in the Funding section of the final published version of this article. The updated text is given below.

This work was supported by the Czech Ministry of Health, the institutional support of hospital research [grant number RVO-VFN 64,165], the Czech Ministry of Health grant [grant number AZV NU22-A-150] and by the National Institute for Neurological Research project funded by the European Union - Next Generation EU (Programme EXCELES, ID Project No. LX22NPO5107).

The authors would like to apologise for any inconvenience caused.

Articles from Multiple Sclerosis and Related Disorders are provided here courtesy of Elsevier

RESOURCES